MORE►
biotech
OncoNano CEO Martin Driscoll [Photo: OncoNano]
OncoNano Expands Research Collaboration With UT Southwestern to Advance New Cancer Therapies
by David Seeley | Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology.
OncoNano raised $50 million in Series B funding in June.
by bionorthTX |
Sep 14, 2021
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit.
The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
MORE►
by Alex Edwards |
Aug 25, 2021
There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.
MORE►
by Alex Edwards |
Aug 10, 2021
A mid-December opening is planned for BioLabs' first central U.S. location in Dallas. Inside the Biotech+ Hub at Pegasus Park, BioLabs will serve as the key operator of the biotech laboratory and 37,000-square-foot flexible life science coworking facility.
MORE►
OncoNano CEO Martin Driscoll [Photo: OncoNano]
Southlake Biotech OncoNano Medicine Raises $50M in Series B to Accelerate Cancer Tech Toward Commercialization
by Alex Edwards | Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
by Alex Edwards |
Mar 8, 2021
As CMO at the Dallas-based biotech, Jessica Hilton is part of a team working to launch the first-ever long-lasting cleaner that can fight COVID-19. It's a job she took during the middle of the global pandemic—and though her home life looks a little different, the mom of three is managing it all through a deep-seeded passion and supportive family.
MORE►
by Quincy Preston |
Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
by Alex Edwards |
Feb 16, 2021
Doloromics, a local therapeutics discovery startup that uses technology to find better ways to treat chronic pain, is one of nine companies selected.
MORE►
LaunchBio Partners With DLA Piper to Accelerate North Texas as a Hub for Life Science Startups
by Alex Edwards | Feb 10, 2021
The agreement will involve the two companies providing educational programs and connections for scientist entrepreneurs located at the Biotech+ Hub at Pegasus Park.
MORE►
by Lauren Hawkins |
Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
by Alex Edwards |
Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE►
by Sandra Engelland |
Nov 10, 2020
The Eos Bioreactor, which also has been featured in Popular Mechanics, uses algae to "eat" CO2.
MORE►
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Photo: Caris]
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by Alex Edwards | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
![Illustration of the Orthofix FIREBIRD SI Fusion System with NANOVATE technology [PHOTO: Business Wire]](https://s24806.pcdn.co/wp-content/uploads/2020/10/Orthofix-970-businesswire-360x203.jpg)
by Quincy Preston |
Oct 7, 2020
The Lewisville-based company's new fusion system is designed to compress and stabilize the sacroiliac joint. Its high-tech features make it the first of its kind specifically designed for SI joint solutions.
Other recent news includes a $10 million partnership with a Swiss medtech firm and a new division president.
Other recent news includes a $10 million partnership with a Swiss medtech firm and a new division president.
MORE►
by Gloria Salinas, Managing Director, Economic Development, DRC |
Oct 1, 2020
Dr. Lynda Stuart of the Bill & Melinda Gates Foundation talked with philanthropist and entrepreneur Lyda Hill in a virtual discussion moderated by Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies.
Here's the takeaway.
Here's the takeaway.
MORE►
